Dr. van der Heijde has received consultant fees, speaking fees, and/or honoraria (less than $10,000 each) from Abbott, Amgen, AstraZeneca, BMS, Janssen (Centocor), Chugai, Eli-Lilly, GSK, Merck, Novartis, Otsuka, Pfizer, Roche, Sanofi- Aventis, Schering-Plough, UCB, and Wyeth.
Comparison of three methods for calculating the Bath Ankylosing Spondylitis Metrology Index in a randomized placebo-controlled study†
Article first published online: 28 NOV 2012
Copyright © 2012 by the American College of Rheumatology
Arthritis Care & Research
Volume 64, Issue 12, pages 1919–1922, December 2012
How to Cite
van der Heijde, D., Deodhar, A., Inman, R. D., Braun, J., Hsu, B. and Mack, M. (2012), Comparison of three methods for calculating the Bath Ankylosing Spondylitis Metrology Index in a randomized placebo-controlled study. Arthritis Care Res, 64: 1919–1922. doi: 10.1002/acr.21771
ClinicalTrials.gov identifier: NCT00265083.
- Issue published online: 28 NOV 2012
- Article first published online: 28 NOV 2012
- Accepted manuscript online: 27 JUN 2012 11:27AM EST
- Manuscript Accepted: 12 JUN 2012
- Manuscript Received: 11 JAN 2012
- Janssen Pharmaceutical Research & Development, LLC